Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer
Clinical trial NCT06475599 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06475599
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2027-12-01
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.